top of page
About
Team
Management
Board Of Directors
Scientific Advisory Board
Scientific and Regulatory Advisors
Clinical
News
Contact
Targeted Solutions for Weight Management and Metabolic Health
Response Pharmaceuticals’ Drug Candidate for the Treatment of Antipsychotic-Induced Weight Gain (AIWG) Achieves Primary Endpoint in Phase 1b Clinical Trial
April 23, 2024
Response Pharmaceuticals Announces Successful Completion of Phase 1B Clinical Trial for RDX-002
August 17, 2023
Response Pharmaceuticals Closes Series A Financing
November 21, 2022
About
Team
Management
Board Of Directors
Scientific Advisory Board
Scientific and Regulatory Advisors
Clinical
News
Contact
bottom of page
